Cargando…
Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies
BACKGROUND: Early antifungal therapy for invasive aspergillosis (IA) has been associated with improved outcome. Traditionally, of empiric antifungal therapy has been used for clinically suspected IA. We compared outcomes of patients with hematologic malignancy and IA who were treated with voriconazo...
Autores principales: | Dib, Rita Wilson, Hachem, Ray Y., Chaftari, Anne-Marie, Ghaly, Fady, Jiang, Ying, Raad, Issam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293532/ https://www.ncbi.nlm.nih.gov/pubmed/30545320 http://dx.doi.org/10.1186/s12879-018-3584-9 |
Ejemplares similares
-
Comparing Diagnostic-Driven Approaches to Empiric Therapy in the Treatment of Invasive Aspergillosis in Patients with Hematologic Malignancy
por: Dib, Rita Wilson, et al.
Publicado: (2017) -
272. Invasive Pulmonary Aspergillosis: Comparative Analysis in cancer patients with Underlying Hematologic Malignancy vs. Solid Tumor
por: Wilson Dib, Rita, et al.
Publicado: (2019) -
1488. Invasive Pulmonary Aspergillosis in Patients with Solid Tumors: Risk Factors and Predictors of Clinical Outcomes
por: Dandachi, Dima, et al.
Publicado: (2018) -
Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients
por: Dib, Rita Wilson, et al.
Publicado: (2018) -
Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: Dagher, Hiba, et al.
Publicado: (2022)